From Research to Practice: How Artificial Intelligence is Transforming Clinical Neurology

From Research to Practice: How Artificial Intelligence is Transforming Clinical Neurology

Artificial intelligence (AI) has long promised to revolutionize medicine. However, there exists a considerable chasm between the promise generated in research laboratories and the concrete application in daily clinical practice—filled with regulatory, cultural, technical, and ethical obstacles. A recent article published in the prestigious scientific journal Nature puts this challenge in perspective, specifically analyzing the field of neurology and how AI can, indeed, move from paper to the hands of doctors and patients.

---

The Current State of AI in Health

In recent years, the ecosystem of AI startups focused on health has grown exponentially. According to data from the Tracxn platform, hundreds of AI-native companies in the health sector are already operating globally, developing everything from diagnostic imaging algorithms to clinical decision support systems. A survey published in JAMA Health Forum in 2025 by Nguyen and collaborators confirmed that the adoption of AI in the health sector has been steadily increasing, although still unevenly across different specialties and regions.

Another study, published in NEJM AI, went further and characterized the clinical adoption of AI medical devices through health insurance data in the United States—a critical thermometer for measuring how much these tools are actually being used in real consultations and procedures.

---

Why Neurology is a Strategic Field for AI

Neurology is one of the most complex medical specialties and has a high demand for diagnostic support tools. Diseases such as epilepsy, multiple sclerosis, Alzheimer’s, Parkinson’s, and stroke (cerebrovascular accident) are conditions that require the interpretation of large volumes of clinical data, imaging exams, electrophysiological signals, and patient history—which is exactly the type of task in which machine learning algorithms have shown impressive performance.

One of the most concrete examples cited in recent scientific literature is the automated interpretation of electroencephalograms (EEGs). A study published in JAMA Neurology in 2023 by Tveit and collaborators showed that AI systems can interpret clinical EEGs with accuracy comparable to that of human specialists—something that, if consolidated, could drastically increase access to epilepsy diagnosis, especially in regions with a shortage of neurologists.

---

The Main Obstacles to Clinical Adoption

Despite the proven technical potential, the path of AI from research to the clinic is riddled with barriers. The Nature article highlights the major bottlenecks:

1. Rigorous Clinical Validation

Many AI models are developed and tested on specific datasets, often sourced from large academic centers. When these models are applied in different clinical environments—with distinct equipment, varied populations, and specific workflows—their performance can drop significantly. Generalization is one of the biggest technical challenges.

2. Regulation and Approval

In the United States, the FDA (Food and Drug Administration) has approved dozens of AI medical devices, but the regulatory process is still slow and complex. In Brazil, ANVISA faces similar challenges in creating agile regulatory frameworks that keep pace with the speed of technological innovation without compromising patient safety.

3. Integration with Hospital Systems

Even when an algorithm is approved and validated, integrating it into electronic health record systems, clinical workflows, and hospital routines is a complex task. A survey published in the Journal of the American Medical Informatics Association in 2025 revealed that the main obstacles reported by health systems include technological integration, cultural resistance from professionals, and lack of data infrastructure.

4. Trust of Clinicians

Doctors—especially neurologists with decades of experience—need to trust the tools they use. AI models that act as "black boxes", providing diagnoses without understandable explanations, naturally generate resistance. The field of explainable AI (XAI) arises precisely to address this problem, making the decision-making processes of algorithms more transparent.

5. Ethical and Equity Issues

There is growing concern about algorithmic biases: if training data does not adequately represent different ethnic groups, age ranges, or socioeconomic conditions, the models may produce less accurate—or even discriminatory—results for underrepresented populations.

---

Promising Use Cases in Neurology

In addition to automated EEG, various AI applications in neurology have already shown promising results in clinical studies:

• Early detection of Alzheimer’s through analysis of magnetic resonance imaging and biomarkers in cerebrospinal fluid
• Screening for ischemic stroke with automatic analysis of emergency computed tomography scans, reducing treatment time
• Remote monitoring of Parkinson’s through wearable sensors that detect tremor and bradykinesia patterns
• Differential diagnosis of multiple sclerosis with advanced analysis of lesions in magnetic resonance imaging
• Prediction of epileptic seizures based on continuous outpatient EEG data

---

What is Needed to Accelerate the Transition

For neurological AI to definitively move from scientific articles to clinics and hospitals, experts recommend a series of structural measures:

1. Creation of diverse and open databases to train more robust and generalizable models
2. Closer partnerships between academia, industry, and health systems for prospective validation in real-world settings
3. Training of health professionals to understand, use, and supervise AI tools
4. Adaptive regulatory frameworks that allow for agile approval without compromising safety
5. Investment in health data infrastructure, especially in developing countries like Brazil

---

Brazil's Role in This Transformation

Brazil has one of the largest public health systems in the world—the SUS—and faces chronic challenges of specialist shortages in remote regions. In this context, AI in neurology can represent a powerful tool for democratizing access to specialized diagnosis. Initiatives such as the Artificial Intelligence Program of the Hospital das Clínicas in São Paulo and partnerships with federal universities already point to a national ecosystem in the making.

However, for Brazil not to remain merely a consumer of foreign-developed technologies, it is essential to invest in national research, training talents in AI and health, and creating public policies that encourage responsible innovation in this sector.

---

Conclusion

The article in Nature is both a warning and a roadmap. AI has the proven potential to transform neurology—making diagnoses faster, more accessible, and more accurate. But this transformation will not happen on its own. It requires multidisciplinary collaboration, political will, investment in infrastructure, and, above all, an unwavering commitment to patient safety and well-being.

The question is no longer if AI will revolutionize clinical neurology. The question is when—and who will be prepared to lead this transition.

---

Main references: Nature (2025); JAMA Health Forum, Nguyen et al. (2025); NEJM AI, Wu et al. (2024); JAMIA, Poon et al. (2025); JAMA Neurology, Tveit et al. (2023).